Get the Stockscreener App
9.07
3.90%
-0.38
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
What is William Blair’s Estimate for RCKT Q1 Earnings? - Defense World
What is Leerink Partnrs’ Estimate for RCKT Q2 Earnings? - Defense World
Chardan Capital Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $54.00 - Defense World
Needham & Company LLC Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $42.00 - Defense World
Rocket Pharmaceuticals price target lowered to $15 from $29 at Goldman Sachs - MSN
When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit? - Yahoo Finance Australia
Decoding Rocket Pharmaceuticals Inc (RCKT): A Strategic SWOT Ins - GuruFocus.com
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus - MSN
Rocket Pharmaceuticals Advances Gene Therapy Pipeline - TipRanks
Rocket Pharmaceuticals (NASDAQ:RCKT) Posts Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month LowHere's What Happened - MarketBeat
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Reiterated with $32 Price Target - TipRanks
Rocket Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Rocket Pharmaceuticals Rings the Opening Bell - Nasdaq
Cantor Fitzgerald cuts Rocket Pharmaceuticals target to $50 By Investing.com - Investing.com Canada
Rocket Pharmaceuticals price target lowered to $54 from $62 at Chardan - TipRanks
Rocket Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Rocket Pharmaceuticals: Q4 Earnings Snapshot - The Washington Post
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress - BioSpace
Rocket Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Rocket Pharmaceuticals: Q4 Earnings Snapshot -February 27, 2025 at 04:15 pm EST - Marketscreener.com
ROCKET PHARMACEUTICALS, INC. SEC 10-K Report - TradingView
Gene Therapy Pioneer Rocket Pharmaceuticals Secures Funding Through 2026 Despite Wider Losses - StockTitan
Rocket Pharmaceuticals Inc (RCKT) may enjoy gains as insiders got busy in the recent days - Knox Daily
Selling Rocket Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St
Rocket Pharmaceuticals Executives Cash Out: See Who Sold Big! - TipRanks
Rocket Pharmaceuticals (RCKT) Projected to Post Quarterly Earnings on Monday - Defense World
Long Term Trading Analysis for (RCKT) - Stock Traders Daily
2 Soaring Stocks to Hold for the Next 20 Years - The Globe and Mail
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week LowHere's Why - MarketBeat
Sovran Advisors LLC Acquires New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
RCKT stock touches 52-week low at $9.76 amid market challenges - MSN
Strategic Financial Concepts LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharma Is A Buy At These Prices With Promising Data (NASDAQ:RCKT) - Seeking Alpha
Jennison Associates LLC Purchases 29,564 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
It makes sense and dollars to buy Rocket Pharmaceuticals Inc (RCKT) stock - SETE News
(RCKT) Long Term Investment Analysis - Stock Traders Daily
Rocket Pharmaceuticals Inc (RCKT) Shares Plummet Below 1-Year High - The News Heater
What was Rocket Pharmaceuticals Inc (RCKT)’s performance in the last session? - US Post News
Holdings of Rocket Pharmaceuticals Inc (RCKT) are aligned with the stars - SETE News
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by SG Americas Securities LLC - MarketBeat
3.91%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):